A detailed history of Pictet Asset Management Sa transactions in Axonics, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 5,574 shares of AXNX stock, worth $395,642. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,574
Previous 4,173 33.57%
Holding current value
$395,642
Previous $227,000 23.79%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

BUY
$47.99 - $60.21 $67,233 - $84,354
1,401 Added 33.57%
5,574 $281,000
Q4 2022

Feb 13, 2023

BUY
$59.56 - $76.6 $248,543 - $319,651
4,173 New
4,173 $261,000

Others Institutions Holding AXNX

About Axonics, Inc.


  • Ticker AXNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 49,123,600
  • Market Cap $3.49B
  • Description
  • Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...
More about AXNX
Track This Portfolio

Track Pictet Asset Management Sa Portfolio

Follow Pictet Asset Management Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pictet Asset Management Sa, based on Form 13F filings with the SEC.

News

Stay updated on Pictet Asset Management Sa with notifications on news.